These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 413042)

  • 1. Sensitivity to 5-fluorocytosine and virulence for mice of some human isolates of Aspergillus.
    Nobre G
    Mycopathologia; 1977 Nov; 62(1):57-60. PubMed ID: 413042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
    Kitahara M; Seth VK; Medoff G; Kobayashi GS
    Antimicrob Agents Chemother; 1976 Jun; 9(6):915-9. PubMed ID: 820247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.
    Martinez J; Torres JM; Arteaga F; Foz-Tena A
    Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mode of action of 5-fluorocytosine in Aspergillus species.
    Wagner GE; Shadomy S
    Chemotherapy; 1979; 25(2):61-9. PubMed ID: 156110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
    Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
    Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.
    Colombo AL; McGough DA; Rinaldi MG
    Mycopathologia; 1994 Dec; 128(3):129-33. PubMed ID: 7739726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causative Agents of Aspergillosis Including Cryptic Aspergillus Species and A. fumigatus].
    Toyotome T
    Med Mycol J; 2016; 57(4):J149-J154. PubMed ID: 27904060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An opportunistic human pathogen on the fly: strains of Aspergillus flavus vary in virulence in Drosophila melanogaster.
    Ramírez-Camejo LA; Torres-Ocampo AP; Agosto-Rivera JL; Bayman P
    Med Mycol; 2014 Feb; 52(2):211-9. PubMed ID: 24577003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electron microscopic aspects of opportunistic fungi after pretreatment].
    Dockx P
    Dermatologica; 1979; 159(1):214-24. PubMed ID: 114432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R; Pina-Vaz C; Rodrigues AG
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastase and elastase inhibitor from Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.
    Okumura Y; Ogawa K; Nikai T
    J Med Microbiol; 2004 May; 53(Pt 5):351-354. PubMed ID: 15096542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolinone derivatives as potential antimicrobial agents.
    Singh SP; Jha K
    Zentralbl Mikrobiol; 1989; 144(2):105-9. PubMed ID: 2501946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.
    Sugita C; Makimura K; Uchida K; Yamaguchi H; Nagai A
    Med Mycol; 2004 Oct; 42(5):433-7. PubMed ID: 15552645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
    Krishnan S; Manavathu EK; Chandrasekar PH
    Mycoses; 2009 May; 52(3):206-22. PubMed ID: 19207851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus.
    Pasqualotto AC
    Med Mycol; 2009; 47 Suppl 1():S261-70. PubMed ID: 18654921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensibilisation of asthmatic patients to extracted antigens from strains of Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.
    Zanjani LS; Bakhtiari A; Sabokbar A; Khosravi AR; Bahonar A; Memarnejadian A
    J Mycol Med; 2012 Mar; 22(1):58-63. PubMed ID: 23177815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methotrexate on the germination and growth of Aspergillus fumigatus and Aspergillus flavus strains.
    Warnock DW; Oliver DA; Cheung MM; Zurick NJ
    J Antimicrob Chemother; 1992 Apr; 29(4):375-81. PubMed ID: 1607326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus species.
    Alp S; Arikan S
    J Basic Microbiol; 2008 Oct; 48(5):331-7. PubMed ID: 18759239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.